Enteroscopic evaluation of the gastrointestinal tract in symptomatic patients with hereditary hemorrhagic telangiectasia

被引:3
|
作者
Proctor, DD
Henderson, KJ
Dziura, JD
Longacre, AV
White, RI
机构
[1] Yale Univ, Sch Med, Dept Internal Med, Sect Digest Dis, New Haven, CT 06520 USA
[2] Yale Univ, Sch Med, Dept Diagnost Radiol, New Haven, CT 06510 USA
[3] Yale Univ, Sch Med, Gen Clin Res Ctr, New Haven, CT 06510 USA
[4] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA
关键词
hereditary hemorrhagic telangiectasia; GI bleeding; arteriovenous malformations; anemia; enteroscopy;
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objectives: Hereditary hemorrhagic telangiectasia is an autosomal dominant disease in which 25% to 30% of patients will develop gastrointestinal bleeding from telangiectases. The extent of telangiectases has not been previously evaluated. This cross-sectional study compared the presence, number, and size of telangiectases in the stomach and duodenum to those in the jejunum using enteroscopy. Methods: At the Yale University Vascular Malformation Center, 30 consecutive, symptomatic adult patients with hereditary hemorrhagic telangiectasia were evaluated using a 220-cm-length enteroscope. The number and size of the telangiectases were documented in the esophagus, proximal and distal stomach, four parts of the duodenum, and every 20 cm in the jejunum. The indication for the procedure was recorded as anemia, gastrointestinal bleeding, or anemia out of proportion to epistaxis. Results: The results of 27 patients were analyzed. A total of 89% of patients had telangiectases in the first 60 cm of the jejunum. In individual patients, there was a strong correlation between the number of telangiectases in the stomach/duodenum when compared with the jejunum. In group analysis, the median number of telangiectases in the stomach and duodenum was significantly higher than in the jejunum (13 vs. 3; Wilcoxon signed rank test, P = 0.001). The presence of large ( greater than or equal to 5 mm) telangiectases in the stomach/duodenum did not necessarily indicate that there would be large telangiectases in the jejunum. Conclusions: The presence and number of stomach and duodenal telangiectases correlated with the presence and number of jejunal ones. However, the occurrence of large proximal telangiectases was not associated with large distal ones.
引用
收藏
页码:115 / 119
页数:5
相关论文
共 50 条
  • [21] Gastrointestinal Bleeding in Patients with Hereditary Hemorrhagic Telangiectasia: Risk Factors and Endoscopic Findings
    Maria Mora-Lujan, Jose
    Iriarte, Adriana
    Alba, Esther
    Angel Sanchez-Corral, Miguel
    Berrozpe, Ana
    Cerda, Pau
    Cruellas, Francesc
    Ribas, Jesus
    Castellote, Jose
    Riera-Mestre, Antoni
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (01)
  • [22] An evaluation of the severity and progression of epistaxis in hereditary hemorrhagic telangiectasia 1 versus hereditary hemorrhagic telangiectasia 2
    Hunter, Benjamin N.
    Timmins, Benjamin H.
    McDonald, Jamie
    Whitehead, Kevin J.
    Ward, P. Daniel
    Wilson, Kevin F.
    LARYNGOSCOPE, 2016, 126 (04): : 786 - 790
  • [23] Symptomatic children with hereditary hemorrhagic telangiectasia - A pediatric center experience
    Mei-Zahav, Meir
    Letarte, Michelle
    Faughnan, Marie E.
    Abdalla, Salma A.
    Cymerman, Ursula
    MacLusky, Ian B.
    ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 2006, 160 (06): : 596 - 601
  • [24] Regression of cutaneous and gastrointestinal telangiectasia with sirolimus and aspirin in a patient with hereditary hemorrhagic telangiectasia
    McAlister, VC
    ANNALS OF INTERNAL MEDICINE, 2006, 144 (03) : 226 - 227
  • [25] Emerging role of bevacizumab in management of patients with symptomatic hepatic involvement in Hereditary Hemorrhagic Telangiectasia
    Chavan, Ajay
    Schumann-Binarsch, Silke
    Schmuck, Bernhard
    Oltmer, Franziska
    Geisthoff, Urban
    Hoppe, Florian
    Wirsching, Kornelia
    Klempnauer, Juergen
    Manns, Michael
    Thomas, Rohit Philip
    Koehne, Claus-Henning
    AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (11) : E641 - E644
  • [26] Utility of bevacizumab in chronic gastrointestinal bleeding in hereditary hemorrhagic telangiectasia
    Gutierrez-Macias, A.
    Barroso-Benayos, I.
    Burzako-Sanchez, A.
    REVISTA DE GASTROENTEROLOGIA DE MEXICO, 2023, 88 (04): : 433 - 434
  • [27] Aflibercept for Gastrointestinal Bleeding in Hereditary Hemorrhagic Telangiectasia: A Case Report
    Villanueva, Bernat
    Iriarte, Adriana
    Torres-Iglesias, Raquel
    Munoz Bolano, Miriam
    Cerda, Pau
    Riera-Mestre, Antoni
    MEDICINA-LITHUANIA, 2023, 59 (09):
  • [28] Management of Refractory Gastrointestinal Bleeding in Hereditary Hemorrhagic Telangiectasia with Bevacizumab
    Masood, Muaaz
    Coles, Michael
    Sifuentes, Humberto
    CASE REPORTS IN GASTROINTESTINAL MEDICINE, 2021, 2021
  • [29] Management of Refractory Gastrointestinal Bleeding in Hereditary Hemorrhagic Telangiectasia With Bevacizumab
    Masood, Muaaz
    Coles, Michael J.
    Asfari, Maysara
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S1174 - S1174
  • [30] Hormonal therapy for the treatment of gastrointestinal bleeding in hereditary hemorrhagic telangiectasia
    Proctor, Deborah D.
    Henderson, Katharine J.
    Dziura, James D.
    White, Robert I., Jr.
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2008, 42 (06) : 756 - 757